blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3011345

EP3011345 - ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) BIOMARKER PROTEINS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.08.2018
Database last updated on 02.09.2024
FormerThe patent has been granted
Status updated on  01.09.2017
FormerGrant of patent is intended
Status updated on  18.05.2017
FormerExamination is in progress
Status updated on  03.02.2017
Most recent event   Tooltip17.07.2020Lapse of the patent in a contracting state
New state(s): AL
published on 19.08.2020  [2020/34]
Applicant(s)For all designated states
Alexion Pharmaceuticals, Inc.
100 College Street
New Haven, CT 06510 / US
[N/P]
Former [2017/31]For all designated states
Alexion Pharmaceuticals, Inc.
100 College St.
New Haven, Connecticut 06510 / US
Former [2016/17]For all designated states
Alexion Pharmaceuticals, Inc.
352 Knotter Drive
Cheshire, CT 06410 / US
Inventor(s)01 / MCKNIGHT, Susan Faas
14 Stonewood Drive
Old Lyme, CT 06371 / US
02 / COFIELL, Roxanne
83 Needletree Lane
Glastonbury, CT 06033 / US
03 / KUKREJA, Anjli
30 Memory Lane
Fairfield, CT 06824 / US
04 / BEDARD, Krystin, A.
deceased / US
05 / YAN, Yan
18 North Pond Road
Cheshire, CT 06410 / US
 [2017/40]
Former [2016/17]01 / MCKNIGHT, Susan Faas
14 Stonewood Drive
Old Lyme, CT 06371 / US
02 / COFIELL, Roxanne
83 Needletree Lane
Glastonbury, CT 06033 / US
03 / KUKREJA, Anjli
30 Memory Lane
Fairfield, CT 06824 / US
04 / BEDARD, Krystin, A.
-
''deceased'' / US
05 / YAN, Yan
18 North Pond Road
Cheshire, CT 06410 / US
Representative(s)J A Kemp LLP
80 Turnmill Street
London EC1M 5QU / GB
[N/P]
Former [2017/40]J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
Former [2016/17]Tuxworth, Pamela M.
J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
Application number, filing date14752744.406.08.2014
[2016/17]
WO2014US49957
Priority number, dateUS201361863299P07.08.2013         Original published format: US 201361863299 P
US201361913180P06.12.2013         Original published format: US 201361913180 P
[2016/17]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2015021166
Date:12.02.2015
Language:EN
[2015/06]
Type: A2 Application without search report 
No.:EP3011345
Date:27.04.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 12.02.2015 takes the place of the publication of the European patent application.
[2016/17]
Type: B1 Patent specification 
No.:EP3011345
Date:04.10.2017
Language:EN
[2017/40]
Search report(s)International search report - published on:EP07.05.2015
ClassificationIPC:C07K16/18, G01N33/68, A61K39/00
[2017/19]
CPC:
G01N33/6893 (EP,EA,KR,US); C07K16/18 (EA,US); A61P13/12 (EP);
A61P43/00 (EP); G01N33/6863 (EA,US); A61K2039/505 (EA,US);
C07K2317/21 (EA,US); C07K2317/24 (EA,US); C07K2317/54 (EA,US);
C07K2317/55 (EA,US); C07K2317/622 (EA,US); C07K2317/626 (EA,US);
C07K2317/76 (EA,US); G01N2333/4716 (EP,EA,KR,US); G01N2333/485 (EA,US);
G01N2333/522 (EP,EA,KR,US); G01N2333/5412 (EA,US); G01N2333/5421 (EA,US);
G01N2333/5434 (EA,US); G01N2333/545 (EA,US); G01N2333/57 (EA,US);
G01N2333/70503 (EP,EA,KR,US); G01N2333/70525 (EA,US); G01N2333/70539 (EP,EA,KR,US);
G01N2333/7151 (EP,EA,KR,US); G01N2333/745 (EA,KR); G01N2333/7452 (EP,EA,US);
G01N2333/75 (EP,EA,US); G01N2333/775 (EP,EA,US); G01N2333/8139 (EP,EA,KR,US);
G01N2333/8146 (EP,EA,KR,US); G01N2333/974 (EP,EA,KR,US); G01N2800/226 (EP,EA,KR,US);
G01N2800/347 (EA,US); G01N2800/50 (EP,EA,US); G01N2800/52 (EP,EA,US);
Y02A50/30 (EP) (-)
Former IPC [2016/17]G01N33/68
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/17]
Extension statesBA18.01.2016
ME18.01.2016
TitleGerman:BIOMARKERPROTEINE FÜR DAS ATYPISCHE HÄMOLYTISCHE URÄMISCHE SYNDROM (AHUS)[2016/17]
English:ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) BIOMARKER PROTEINS[2016/17]
French:PROTÉINES DE BIO-MARQUEURS DE SYNDROME HÉMOLYTIQUE ET URÉMIQUE ATYPIQUE[2016/17]
Entry into regional phase18.01.2016National basic fee paid 
18.01.2016Designation fee(s) paid 
18.01.2016Examination fee paid 
Examination procedure18.01.2016Amendment by applicant (claims and/or description)
18.01.2016Examination requested  [2016/17]
19.05.2016Despatch of a communication from the examining division (Time limit: M04)
11.07.2016Reply to a communication from the examining division
11.10.2016Despatch of a communication from the examining division (Time limit: M04)
31.01.2017Reply to a communication from the examining division
19.05.2017Communication of intention to grant the patent
04.08.2017Fee for grant paid
04.08.2017Fee for publishing/printing paid
04.08.2017Receipt of the translation of the claim(s)
Divisional application(s)EP17182174.7  / EP3290922
EP23206495.6
Opposition(s)05.07.2018No opposition filed within time limit [2018/37]
Fees paidRenewal fee
29.08.2016Renewal fee patent year 03
28.08.2017Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU06.08.2014
AL04.10.2017
CY04.10.2017
CZ04.10.2017
DK04.10.2017
EE04.10.2017
FI04.10.2017
HR04.10.2017
LT04.10.2017
LV04.10.2017
MC04.10.2017
MK04.10.2017
PL04.10.2017
PT04.10.2017
RO04.10.2017
RS04.10.2017
SK04.10.2017
SM04.10.2017
BG04.01.2018
NO04.01.2018
GR05.01.2018
IS04.02.2018
[2020/34]
Former [2020/31]HU06.08.2014
CY04.10.2017
CZ04.10.2017
DK04.10.2017
EE04.10.2017
FI04.10.2017
HR04.10.2017
LT04.10.2017
LV04.10.2017
MC04.10.2017
MK04.10.2017
PL04.10.2017
PT04.10.2017
RO04.10.2017
RS04.10.2017
SK04.10.2017
SM04.10.2017
BG04.01.2018
NO04.01.2018
GR05.01.2018
IS04.02.2018
Former [2020/30]HU06.08.2014
CZ04.10.2017
DK04.10.2017
EE04.10.2017
FI04.10.2017
HR04.10.2017
LT04.10.2017
LV04.10.2017
MC04.10.2017
PL04.10.2017
PT04.10.2017
RO04.10.2017
RS04.10.2017
SK04.10.2017
SM04.10.2017
BG04.01.2018
NO04.01.2018
GR05.01.2018
IS04.02.2018
Former [2020/28]CZ04.10.2017
DK04.10.2017
EE04.10.2017
FI04.10.2017
HR04.10.2017
LT04.10.2017
LV04.10.2017
MC04.10.2017
PL04.10.2017
PT04.10.2017
RO04.10.2017
RS04.10.2017
SK04.10.2017
SM04.10.2017
BG04.01.2018
NO04.01.2018
GR05.01.2018
IS04.02.2018
Former [2019/15]CZ04.10.2017
DK04.10.2017
EE04.10.2017
FI04.10.2017
HR04.10.2017
LT04.10.2017
LV04.10.2017
MC04.10.2017
PL04.10.2017
RO04.10.2017
RS04.10.2017
SK04.10.2017
SM04.10.2017
BG04.01.2018
NO04.01.2018
GR05.01.2018
IS04.02.2018
Former [2018/40]CZ04.10.2017
DK04.10.2017
EE04.10.2017
FI04.10.2017
HR04.10.2017
LT04.10.2017
LV04.10.2017
PL04.10.2017
RO04.10.2017
RS04.10.2017
SK04.10.2017
SM04.10.2017
BG04.01.2018
NO04.01.2018
GR05.01.2018
IS04.02.2018
Former [2018/37]CZ04.10.2017
DK04.10.2017
EE04.10.2017
FI04.10.2017
HR04.10.2017
LT04.10.2017
LV04.10.2017
PL04.10.2017
RS04.10.2017
SK04.10.2017
SM04.10.2017
BG04.01.2018
NO04.01.2018
GR05.01.2018
IS04.02.2018
Former [2018/35]CZ04.10.2017
DK04.10.2017
EE04.10.2017
FI04.10.2017
HR04.10.2017
LT04.10.2017
LV04.10.2017
RS04.10.2017
SK04.10.2017
BG04.01.2018
NO04.01.2018
GR05.01.2018
IS04.02.2018
Former [2018/24]FI04.10.2017
HR04.10.2017
LT04.10.2017
LV04.10.2017
RS04.10.2017
BG04.01.2018
NO04.01.2018
GR05.01.2018
IS04.02.2018
Former [2018/22]FI04.10.2017
LT04.10.2017
NO04.01.2018
Cited inInternational search[Y]WO2011137395  (ROTHER RUSSELL P [US], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.